|
1.
|
|
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101). 2024/04
|
|
2.
|
|
Predictors of in-hospital mortality in elderly unvaccinated patients during SARS-CoV-2 Alpha variants epidemic. 2024/03
|
|
3.
|
|
Usefulness of High-resolution Computed Tomography for Macrolide Therapy of Idiopathic Bronchiectasis. 2023/08
|
|
4.
|
|
A Convenient Risk Prediction Score for COVID-19 for Determining Whether or Not Hospitalization Is Recommended: Kanagawa Admission Priority Assessment Score. 2022/07
|
|
5.
|
|
Vision Improvement after Osimertinib Treatment in Paraneoplastic Optic Neuropathy Associated with Lung Adenocarcinoma. 2021/07
|
|
6.
|
|
Localized pleural metastasis without other organ metastases after nephrectomy for renal cell carcinoma. 2021/03
|
|
7.
|
|
Case report: potential treatment of metastatic amphicrine carcinoma of the rectum with FOLFOXIRI chemotherapy. 2020/11
|
|
8.
|
|
Correlation between the expression of folate receptor alpha (FRα) and clinicopathological features in patients with lung adenocarcinoma. 2020/07
|
|
9.
|
|
Successful treatment with methyl-prednisolone pulses for the late phase of COVID-19 with respiratory failure: A single-center case series. 2020
|
|
10.
|
|
Efficacy of subsequent docetaxel +/- ramucirumab and S-1 after nivolumab for patients with advanced non-small cell lung cancer. 2019/05
|
|
11.
|
|
Prognostic Factors for Non-small Cell Lung Cancer Treated with Carboplatin, Paclitaxel, and Bevacizumab. 2018
|
|
Display 5 items
|
|
Display all(11)
|
